ACTIVE

APOTHEEK BLOEMENDAAL

Financial year 2025 · Closed on 31/12/2025

Net result17,6 k €-85,4 %over 1 year
Gross margin349,2 k €-8,8 %over 1 year
Equity540,8 k €+2,6 %over 1 year
Workforce2,4 ETP-11,1 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK BLOEMENDAAL is a Private limited company incorporated in 2007. Its registered office is in Schoten. It employs on average 2,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0889.422.692
Incorporation
14/05/2007
Legal form
Private limited company
Registered office
Paalstraat 245
2900 Schoten · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
2,4 ETP
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 18 filings

Trend over 10 financial years

20252024202320222021
Income statement
Gross margin349,2 k €382,9 k €384 k €318,2 k €243,7 k €
EBITDA160,3 k €231,2 k €178,9 k €210,4 k €169 k €
Operating result87,6 k €200,2 k €152,3 k €191 k €154 k €
Net result17,6 k €120,7 k €84,6 k €117,4 k €104 k €
Balance sheet
Equity540,8 k €527,1 k €452,7 k €398,2 k €310,7 k €
Total assets2,1 M €1,2 M €1,1 M €779,3 k €763,6 k €
Cash73 k €156,8 k €95,3 k €180,5 k €149,2 k €
Debts1,6 M €703,2 k €669,9 k €381,2 k €452,9 k €
Other
Workforce2,4 ETP2,7 ETP2,8 ETP2,2 ETP1,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

JDV PHARMA

Bestuurder · since 01 juillet 2019 · 0538.789.765

Represented by Jeroen De Vleeschouwer

Active

Ended mandates

JDV PHARMA

Director · since 01 juillet 2019 · 0538.789.765

Represented by Jeroen De Vleeschouwer

Ended
JDV Pharma BV

Bestuurder · since 01 juillet 2019

Represented by Jeroen De Vleeschouwer

Ended
Bart De Vleeschouwer

Bestuurder

Ended
Bart De Vleeschouwer

Director

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date27/05/202615/07/202503/04/202418/04/202328/06/202223/06/2021
General meeting21/04/202623/06/202506/03/202404/04/202320/06/202221/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202521/04/202627/05/2026DutchPDF
Abridged model31/12/202423/06/202515/07/2025DutchPDF
Abridged model31/12/202306/03/202403/04/2024DutchPDF
Abridged model31/12/202204/04/202318/04/2023DutchPDF
Abridged model31/12/202120/06/202228/06/2022DutchPDF
Abridged model31/12/202021/06/202123/06/2021DutchPDF
Abridged model31/12/201928/07/202031/08/2020DutchPDF
Abridged model31/12/201817/06/201918/07/2019DutchPDF
Abridged model31/12/201718/06/201817/07/2018DutchPDF
Abridged model31/12/201619/06/201704/08/2017DutchPDF
Abridged model31/12/201520/06/201608/08/2016DutchPDF
Abridged model31/12/201422/06/201513/07/2015DutchPDF
Abridged model31/12/201323/06/201411/08/2014DutchPDF
Abridged model31/12/201217/06/201309/07/2013DutchPDF
Abridged model31/12/201118/06/201226/07/2012DutchPDF
Abridged model31/12/201020/06/201120/07/2011DutchPDF
Abridged model31/12/200921/06/201007/07/2010DutchPDF
Abridged model31/12/200822/06/200919/08/2009DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

JDV PHARMA

Bestuurder · since 01 juillet 2019 · 0538.789.765

Represented by Jeroen De Vleeschouwer

Active

Ended mandates

JDV PHARMA

Director · since 01 juillet 2019 · 0538.789.765

Represented by Jeroen De Vleeschouwer

Ended
JDV Pharma BV

Bestuurder · since 01 juillet 2019

Represented by Jeroen De Vleeschouwer

Ended
Bart De Vleeschouwer

Bestuurder

Ended
Bart De Vleeschouwer

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/07/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares16/01/2018
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares03/01/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other27/12/2007
    DIVERSEN
    PDF
  • Other24/05/2007
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202517,6 k €↓
  2. 2024
    Annual accounts 2024120,7 k €↑
  3. 2023
    Annual accounts 202384,6 k €↓
  4. 2022
    Annual accounts 2022117,4 k €↑
  5. 2021
    Annual accounts 2021104 k €↑
  6. 2012
    Annual accounts 201289,5 k €↑
  7. 2011
    Annual accounts 201175,1 k €↑
  8. 2010
    Annual accounts 201051,9 k €↓
  9. 2009
    Annual accounts 200988,3 k €↑
  10. 2008
    Annual accounts 200887,8 k €
  11. 14/05/2007
    IncorporationPrivate limited company